However, in patients with locally advanced lung adenocarcinoma, tumor‐expressing IFNγ alone has no significant prognostic value, while tumor‐expressing both IFNγ and PD‐L1 have the best value.16 This discrepancy could be due to cancer patient heterogeneity, tumor stage or tumor type. This evidence concerns the gene IFNG and cancer.